Small-molecule inhibitors targeting apoptosis signal-regulated kinase 1

被引:9
|
作者
Wang, Tiantian [1 ,2 ]
Pang, Lidan [1 ]
He, Mengni [1 ]
Wang, Zengtao [1 ]
机构
[1] Jiangxi Univ Chinese Med, Coll Pharm, Nanchang 330004, Peoples R China
[2] Jiangxi Univ Chinese Med, Natl Pharmaceut Engn Ctr Solid Preparat Chinese He, Nanchang 330006, Peoples R China
关键词
ASK1; inhibitors; Reviews; Optimization strategies; Structure-activity relationships; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; NEURONAL CELL-DEATH; ASK1; INHIBITOR; INCREASED VULNERABILITY; DEPENDENT ACTIVATION; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURES; STRUCTURAL BASIS;
D O I
10.1016/j.ejmech.2023.115889
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Apoptosis signal regulated kinase 1 (ASK1, also known as MAP3K5) is a member of the mitogen activated protein kinase kinase kinase (MAP3K) family. Since its first isolation from a human macrophage library in 1996, its research has been ongoing for over 25 years. A large number of reports have revealed that ASK1, as a key activator of the p38 mitogen-activated protein kinase and c-Jun N-terminal kinase (JNK) signaling cascade, responds to various stressors, and its inhibitors have important potential value in the treatment of diseases such as inflammation, cancer, and the nervous system and so on. This review summarizes the recent development in this field, including the structure and signaling pathways of ASK1, with a particular focus on the structureactivity relationships, and the hit-to-lead optimization strategies.
引用
收藏
页数:31
相关论文
共 50 条
  • [41] Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domain
    Shukla, Shirish
    Ying, Weijiang
    Gray, Felicia
    Yao, Yiwu
    Simes, Miranda L.
    Zhao, Qingjie
    Miao, Hongzhi
    Cho, Hyo Je
    Gonzalez-Alonso, Paula
    Winkler, Alyssa
    Lund, George
    Purohit, Trupta
    Kim, EunGi
    Zhang, Xiaotian
    Ray, Joshua M.
    He, Shihan
    Nikolaidis, Caroline
    Ndoj, Juliano
    Wang, Jingya
    Jaremko, Lukasz
    Jaremko, Mariusz
    Ryan, Russell J. H.
    Guzman, Monica L.
    Grembecka, Jolanta
    Cierpicki, Tomasz
    NATURE CHEMICAL BIOLOGY, 2021, 17 (07) : 784 - 793
  • [42] Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1
    Feng, Zhiping
    Hom, Marisa E.
    Bearrood, Thomas E.
    Rosenthal, Zachary C.
    Fernandez, Daniel
    Ondrus, Alison E.
    Gu, Yuchao
    McCormick, Aaron K.
    Tomaske, Madeline G.
    Marshall, Cody R.
    Kline, Toni
    Chen, Che-Hong
    Mochly-Rosen, Daria
    Kuo, Calvin J.
    Chen, James K.
    NATURE CHEMICAL BIOLOGY, 2022, 18 (10) : 1065 - +
  • [43] Identification of novel extracellular signal-regulated kinase docking domain inhibitors
    Hancock, CN
    Macias, A
    Lee, EK
    Yu, SY
    MacKerell, AD
    Shapiro, P
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (14) : 4586 - 4595
  • [44] Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics
    Chen, Hao
    Smaill, Jeff B.
    Liu, Tongzheng
    Ding, Ke
    Lu, Xiaoyun
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 14404 - 14424
  • [45] Development of small-molecule inhibitors targeting adipose triglyceride lipase
    Nicole Mayer
    Martina Schweiger
    Matthias Romauch
    Gernot F Grabner
    Thomas O Eichmann
    Elisabeth Fuchs
    Jakov Ivkovic
    Christoph Heier
    Irina Mrak
    Achim Lass
    Gerald Höfler
    Christian Fledelius
    Rudolf Zechner
    Robert Zimmermann
    Rolf Breinbauer
    Nature Chemical Biology, 2013, 9 : 785 - 787
  • [46] Effective Targeting of the Survivin Dimerization Interface with Small-Molecule Inhibitors
    Qi, Jing
    Dong, Zizheng
    Liu, Jianguo
    Peery, Robert C.
    Zhang, Shaobo
    Liu, Jing-Yuan
    Zhang, Jian-Ting
    CANCER RESEARCH, 2016, 76 (02) : 453 - 462
  • [47] Small-molecule inhibitors specifically targeting type III secretion
    Nordfelth, R
    Kauppi, AM
    Norberg, HA
    Wolf-Watz, H
    Elofsson, M
    INFECTION AND IMMUNITY, 2005, 73 (05) : 3104 - 3114
  • [48] Small-Molecule Inhibitors Targeting eIF4A in Leukemia
    Jia, Xiaofeng
    Zhou, Hong
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2021, 22 (07) : 559 - 566
  • [49] Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
    Alexander J. Muller
    Peggy A. Scherle
    Nature Reviews Cancer, 2006, 6 : 613 - 625
  • [50] Development of small-molecule inhibitors targeting adipose triglyceride lipase
    Mayer, Nicole
    Schweiger, Martina
    Romauch, Matthias
    Grabner, Gernot F.
    Eichmann, Thomas O.
    Fuchs, Elisabeth
    Ivkovic, Jakov
    Heier, Christoph
    Mrak, Irina
    Lass, Achim
    Hoefler, Gerald
    Fledelius, Christian
    Zechner, Rudolf
    Zimmermann, Robert
    Breinbauer, Rolf
    NATURE CHEMICAL BIOLOGY, 2013, 9 (12) : 785 - +